Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  6. 4 Exercise or conversion Vice President - Finance & CFO acquired 200,000 shares (option exercise)
  7. 4 Exercise or conversion Chief Executive Officer acquired 1,000,000 shares (option exercise)
  8. 5 Insider Annual Insider Trading Report
  9. 4 Open-market sale President sold 1,785,905 shares at an average $0.56 ($1,005,318)
  10. 4 Exercise or conversion President acquired 550,000 shares (option exercise)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Exercise or conversion President acquired 600,000 shares (option exercise)
  14. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  15. 4 Grant or award Chief Executive Officer acquired 120,000 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale VP-Finance & CFO sold 15,000 shares at $0.80 ($12,000)
  20. 5 Insider Annual Insider Trading Report

Page 22 of 24 · 471 filings